VVOS · Categories · Form 4

VVOS - SEC Form 4 insider transactions

Vivos Therapeutics Inc. (VVOS) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for VVOS

• 24d
  SEC Form 4 filed by Skaff Michael C

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 515d
  SEC Form 4 filed by Chief Executive Officer Huntsman Ronald Kirk

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 515d
  SEC Form 4 filed by Chief Financial Officer Amman Bradford K.

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 667d
  SEC Form 4 filed by Director Thompson Matthew

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 667d
  SEC Form 4 filed by Director Sokolow Leonard J

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 667d
  SEC Form 4 filed by Chief Executive Officer Huntsman Ronald Kirk

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 667d
  SEC Form 4 filed by Director Lindsay Mark F.

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 667d
  SEC Form 4 filed by Director Green Ralph Elias

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 667d
  SEC Form 4 filed by Director Krammer Anja B

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 667d
  SEC Form 4 filed by Chief Financial Officer Amman Bradford K.

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 1041d
  SEC Form 4 filed by Huntsman Ronald Kirk

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 1041d
  SEC Form 4 filed by Huntsman Ronald Kirk

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 1046d
  SEC Form 4 filed by Huntsman Ronald Kirk

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 1215d
  SEC Form 4: Huntsman Ronald Kirk bought $10,000 worth of shares (20,000 units at $0.50), increasing direct ownership by 73% to 47,500 units

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 1215d
  SEC Form 4 filed by Lindsay Mark F.

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 1215d
  SEC Form 4 filed by Sokolow Leonard J

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 1215d
  SEC Form 4 filed by Krammer Anja B

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 1215d
  SEC Form 4 filed by Thompson Matthew

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 1215d
  SEC Form 4 filed by Amman Bradford K.

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 1215d
  SEC Form 4 filed by Green Ralph Elias

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 1423d
  SEC Form 4: Huntsman Ronald Kirk bought $23,560 worth of shares (12,000 units at $1.96), increasing direct ownership by 77% to 27,500 units

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 1518d
  SEC Form 4 filed by Amman Bradford K.

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 1518d
  SEC Form 4 filed by Huntsman Ronald Kirk

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 1677d
  SEC Form 4: Huntsman Ronald Kirk bought $21,550 worth of Common Stock (5,000 units at $4.31), increasing direct ownership by 48% to 15,500 units

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 1697d
  SEC Form 4 filed by Amman Bradford K.

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 1712d
  SEC Form 4: Huntsman Ronald Kirk bought $15,000 worth of Common Stock (5,000 units at $3.00), increasing direct ownership by 91% to 10,500 units

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 1720d
  SEC Form 4 filed by Singh Gurdev Dave

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 1720d
  SEC Form 4 filed by Krammer Anja B

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 1720d
  SEC Form 4 filed by Green Ralph Elias

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 1720d
  SEC Form 4 filed by Thompson Matthew

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 1720d
  SEC Form 4 filed by SOKOLOW LEONARD J

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 1720d
  SEC Form 4 filed by Lindsay Mark F.

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 1797d
  SEC Form 4: Huntsman Ronald Kirk bought $21,520 worth of Common Stock (4,000 units at $5.38), increasing direct ownership by 267% to 5,500 units

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 1797d
  SEC Form 4: Amman Bradford K. bought $5,290 worth of Common Stock (1,000 units at $5.29), increasing direct ownership by 100% to 2,000 units

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 1866d
  SEC Form 4 filed by K. Bradford Amman

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)

Other VVOS categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends